2Labialle S,Gayet L, Marthinet E, et al. Tranacriptional Regulators of the Human Multidrug Resistance 1 Gene:Recent Views [J]. Biochem Pharmacol,2002,64(5/6):943-948.
3Tokunaga Y, Hosogi H, Hoppou T, et al. Effects oI MDRI/P-glycoprotein Expression on Prognosis in advanced Colorectal Cancer after Surgery[J]. Oncol Rep,2001,8(4) :815.
4Yamauchi M,Kumazawa H,Satta T,et al. Prediction of Doxorubicin Resistance in Gastrointestinal Cancer by P-glycoprotein Staining[J]. Eur J Cancer, 1992,28 : 1442-1447.
5Ramachandran C,Wellham L I. Effect of MDRI Phosphorothioate Antisense Oligodeoxynucleotides in Multidrug-resistant Human Tumor Cell Lines and Xenografts[J]. Anticancer Res, 2003,23(3) :2681-2690.
6Wijnholds J. Drug Resistance Caused by Multidrug Resistance-associ ated Proteins[J]. Novartis Found Symp,2002,243 : 69-79.
7Kuo M T, Julian J. Regulation of Multidrug Resistance Gene Mdrl Expression in Isolated Mouse Uterine Epithelial Cells [J]. J Cell Physiol, 1995,164:132-141.
8Fillpits M, Suchomel R W, Dekan G, et al. Expression of the Multidrug Resistance Associated Protein (MRAP) Gene in Colorectal Carcinomas[J]. Br J Cancer, 1997,75 (2) : 208-212.
9Dolfini E, Dasdia T, Arancal G, et al. Characterization of a Clonal Human Colon Adenocarcinoma Line Intrinsically Resistance to Doxorrubicin[J]. Br J Cancer,1997,76(1) :67-76.
10Morgan A S, Ciaccio P J, Tew K D, et al. Lsozyme-specific Glutathione-S-transferase Inhibitors Potentiate Drug Sensitivity in Cultured Human Cell Lines[J].Cancer Chemother Pharmacol, 1996,37(5) :363-370.
4Strul H, Arber N.Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer:the role of super aspirins. Isr Med Assoc 12000;2:695-702.
5Avivi-Green C, Polak-Charcon S, Madar Z, Schwart ZB. Different molecular events account for butyrate-induced apoptosis in two human colon cancer cell lines. J Nutr 2002;132:1812-1818.
6Wang Q, Li N, Wang X, Kim MM, Evers BM. Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3'-kinase inhibition in the KM20 human colon cancer cell line.Clin Cancer Res 2002;8:1940-1947.
7Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 2002;132:1012-1017.
8Oliver L, Cordel S, Barbieux I, LeCabellec MT, Meflah K,Gregoire M, Vallette FM. Resistance to apoptosis is increased during metastatic dissemination of colon cancer. Clin Exp Metastasis 2002;19:175-180.
9Tan S, Seow TK, Liang RC, Koh S, Lee CP, Chung MC, Hooi SC. Proteome analysis of butyrate-treated human colon cancer cells (HT-29). Int J Cancer 2002;98:523-531.
10Giermasz A, Grzela T, Nowis D, Makowski M, Czaika A,Stoklosa T, Lasek W, Dabrowsk A, Wlznerowlez M,Macklewlcz A, Jakoolslak M. Butyric acid enhances in vivo expression of hTNF-alpha in transduced melanoma cell line.Anticancer Res 2001;21:4001-4004.
8Stephanie Hille,Daniel T. Rein,Marion Riffelmann,Rainer Neumann,Judith Sartorius,Andreas Pfützner,Christian M. Kurbacher,Thomas Sch?ndorf,Martina Breidenbach.Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer[J].Anti-Cancer Drugs.2006(9)
9Gerd Stammler,Manfred Volm.Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines[J].Anti-Cancer Drugs.1997(3)
